1. 1 Nowell PC, Hungerford DA: Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. J Natl Cancer Inst 27:1013-1035, 1961
2. 2 Spiers AS: The clinical features of chronic granulocytic leukaemia. Clin Haematol 6:77-95, 1977
3. 3 Kurzrock R, Gutterman JU, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990-998, 1988
4. 4 O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, et al.: Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348:994-1004, 2003
5. 5 Roy L, Guilhot J, Krahnke T, Guerci-Bresler A, Druker BJ, et al.: Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: Historical comparison between two phase 3 trials. Blood 108:1478-1484, 2006